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Background
Psychological stress has been implicated in promoting
cancer recurrence and progression, but the magnitude of
this effect and underlying mechanism remain unclear. In
attempt to address this controversy, we have evaluated
the impact of stress on molecular and cellular compo-
nents of cancer Immune-surveillance and tested the
hypothesis that the impact of stress in promoting tumor-
associated immune suppression is context-dependent.
Materials and methods
Modulatory impact of epinephrine (EPI) was tested ex
vivo, in cultured myeloid cells, CD4+ or CD8+ T cells or
while tumor tissue explant cultures. Celecoxib (COX-2
inhibitor) was used to assess whether EPI mediated gen-
eration of MDSC/Treg involves COX-2 induction. In
order to delineate the specific signaling pathway involved
in EPI mediated induction of suppressive markers in
MDSC, Treg and tumor explant cultures, selective inhi-
bitors of PKA(H89), PKB(MK2206) and p38 MAPK
(PH797804) were used.
Results
Epinephrine showed strong synergy with TNFa and
IL1mediators of tumor-associated inflammation, in the
induction of high levels of mediators of tumor-associated
immune suppression (COX-2, IDO) and Treg-attracting
chemokine, CCL22. Epinephrine-driven immunosuppres-
sive events were highly dependent on the availability of
TNFa or IL1-dirven inflammation. Macrophages cul-
tured in presence of TNFa + EPI suppressed CD3/CD28
stimulated proliferation of naïve CD8+ T cells. CD4+
T cells showed up regulation of suppressive mediator,
IL-10, reduced proliferation and reduced IFNg expression
when stimulated in presence of epinephrine. Suppressive
effects of EPI were antagonized by celecoxib, and blocked
by the combination of propranolol (b2-adrenergic
antagonist) and celecoxib (COX-2 blocker) or by inhibi-
tors of PKA and p38 MAPK pathways.
Conclusions
Current demonstration that immunosuppressive effects
of stress mediators are context-dependent and require
the component of p38MAPK-mediated inflammation
helps to explain current controversy regarding the link
between psychological stress and cancer recurrence/
progression. That interplay between stress, inflammation
and COX-2/PGE2 system in the development of tumor-
associated immunosuppression suggests the possibility of
new combination immunotherapies of cancer, involving
b2-adrenergic antagonists, COX2 blockers and/or or
p38MAPK inhibitors.
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